Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delta Joint Management (DJM) is a specialized clinical research organization (CRO) that provides comprehensive management services for orthopedic clinical trials. The company focuses on medical devices and biologics related to joint replacement, spine, and extremities, offering services such as site selection, data management, and regulatory support. DJM is recognized for its expertise in longitudinal patient tracking and outcomes research, helping orthopedic manufacturers bring innovative technologies to market while ensuring clinical safety and efficacy. The firm supports a wide range of studies, including Investigational Device Exemption (IDE), post-market surveillance, and investigator-initiated trials. By leveraging deep domain expertise in musculoskeletal health, DJM assists clients in navigating complex regulatory pathways and optimizing clinical evidence generation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delta Joint Management.